A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19. <br /> <br />The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants. <br /> <br />Two vaccines have already been rolled out in the UK – from Pfizer and Oxford/AstraZeneca – while a third from Moderna has been approved for use. <br /> <br />The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval. Report by Avagninag. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
